These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9145231)

  • 1. Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.
    Yamakawa I; Ishida M; Kato T; Ando H; Asakawa N
    Biol Pharm Bull; 1997 Apr; 20(4):455-9. PubMed ID: 9145231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
    Ramchandani M; Robinson D
    J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks.
    Ronneberger B; Kao WJ; Anderson JM; Kissel T
    J Biomed Mater Res; 1996 Jan; 30(1):31-40. PubMed ID: 8788103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides.
    Jeong JH; Park TG
    Bioconjug Chem; 2001; 12(6):917-23. PubMed ID: 11716682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide.
    Shakweh M; Fattal E
    J Nanosci Nanotechnol; 2006; 6(9-10):2811-20. PubMed ID: 17048487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleral plug of biodegradable polymers for controlled drug release in the vitreous.
    Hashizoe M; Ogura Y; Kimura H; Moritera T; Honda Y; Kyo M; Hyon SH; Ikada Y
    Arch Ophthalmol; 1994 Oct; 112(10):1380-4. PubMed ID: 7945044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1997 Jul; 16(7):633-9. PubMed ID: 9222079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
    Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
    Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer.
    Isobe M; Yamazaki Y; Oida S; Ishihara K; Nakabayashi N; Amagasa T
    J Biomed Mater Res; 1996 Nov; 32(3):433-8. PubMed ID: 8897149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release.
    Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB
    Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation.
    Wu XS; Wang N
    J Biomater Sci Polym Ed; 2001; 12(1):21-34. PubMed ID: 11334187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins.
    Eliaz RE; Kost J
    J Biomed Mater Res; 2000 Jun; 50(3):388-96. PubMed ID: 10737881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of poly (DL-lactic acid-co-glycolic acid) containing calcium carbonate and hydroxyapatite fillers--effect of size and shape of the fillers--.
    Tsunoda M
    Dent Mater J; 2003 Sep; 22(3):371-82. PubMed ID: 14621002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
    Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
    Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.